Document Detail


Telmisartan Lowers Home Blood Pressure and Improves Insulin Resistance Without Correlation Between Their Changes.
MedLine Citation:
PMID:  21269058     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Telmisartan is an angiotensin type 1 receptor blocker (ARB), which also partially activates liganding peroxisome proliferator-activated receptor gamma. However, the relationship between the effects of telmisartan on hemodynamics and metabolism has not sufficiently been elucidated in clinical settings. We examined the long-term effects of telmisartan on hemodynamics including home blood pressure (BP) and on insulin resistance representing as homeostasis model assessment (HOMA-R). Twenty-seven hypertensive patients were consecutively enrolled at our outpatient department. At entry, all of the participants were previously prescribed another ARB for more than 3 months and then the former ARB were replaced by telmisartan. Hemodynamic and metabolic parameters were measured before treatment and at points 1 and 3 months after treatment with telmisartan. Telmisartan significantly lowered home systolic blood pressure (SBP) and diastolic blood pressure (DBP) (DBP) and improved HOMA-R during the treatment period. However, the changes in home SBP and DBP were not correlated with that of HOMA-R. In conclusion, telmisartan lowers home BP and improves insulin resistance without correlation between their changes.
Authors:
Kazuhiro Kobayashi; Yoichi Ohno; Tsuneo Takenaka; Naofumi Ikeda; Hirokazu Okada; Yoshihiko Kanno; Hiromichi Suzuki
Related Documents :
1608038 - Effects of a new dihydropyridine derivative, frc-8653, on blood pressure in conscious s...
1835898 - Central anp attenuates pressor responses to central avp in wky and shr.
3309518 - A possible explanation of genetic hypertension in the spontaneously hypertensive rat.
20219858 - Cardiovascular effects of arginase inhibition in spontaneously hypertensive rats with f...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-1-26
Journal Detail:
Title:  Clinical and experimental hypertension (New York, N.Y. : 1993)     Volume:  -     ISSN:  1525-6006     ISO Abbreviation:  -     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-1-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9305929     Medline TA:  Clin Exp Hypertens     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Nephrology, Saitama Medical University, Saitama, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparison of the Hypotensive and Bradycardic Activity of Ginkgo, Garlic, and Onion Extracts.
Next Document:  Association of the Human CYP11B2 Gene and Essential Hypertension in Southwest Han Chinese Population...